Anti-FACL4 antibody [EPR17587-42]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(18 Publications)
Rabbit Recombinant Monoclonal FACL4 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, Human samples. Cited in 18 publications.
View Alternative Names
ACS4, FACL4, LACS4, ACSL4, Long-chain-fatty-acid--CoA ligase 4, Arachidonate--CoA ligase, Long-chain acyl-CoA synthetase 4, LACS 4
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-FACL4 antibody [EPR17587-42] (AB205199)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling FACL4 with ab205199 at 1/120 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/500 dilution was used as the secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-FACL4 antibody [EPR17587-42] (AB205199)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling FACL4 with ab205199 at 1/50 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HeLa cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows;
-ve control 1 : ab205199 at 1/50 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-FACL4 antibody [EPR17587-42] (AB205199)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HepG2 (Human liver hepatocellular carcinoma) cells labeling FACL4 with ab205199 at 1/50 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HepG2 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows;
-ve control 1 : ab205199 at 1/50 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FACL4 antibody [EPR17587-42] (AB205199)
Immunohistochemical analysis of paraffin-embedded Human liver carcinoma tissue labeling FACL4 with ab205199 at 1/500 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Cytoplasmic staining on Human hepatocellular carcinoma tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Unknown
Immunoprecipitation - Anti-FACL4 antibody [EPR17587-42] (AB205199)
FACL4 was immunoprecipitated from 1mg of Mouse brain whole cell lysate with ab205199 at 1/40 dilution. Western blot was performed from the immunoprecipitate using ab205199 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : Mouse brain whole cell lysate 10 μg (Input). Lane 2 : ab205199 IP in Mouse brain whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab205199 in Mouse brain whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 8 seconds
All lanes:
Immunoprecipitation - Anti-FACL4 antibody [EPR17587-42] (ab205199)
Predicted band size: 79 kDa
false
- WB
Supplier Data
Western blot - Anti-FACL4 antibody [EPR17587-42] (AB205199)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FACL4 antibody [EPR17587-42] (ab205199) at 1/5000 dilution
Lane 1:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 44 kDa,79 kDa
Observed band size: 24 kDa,44 kDa,72 kDa,79 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-FACL4 antibody [EPR17587-42] (AB205199)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FACL4 antibody [EPR17587-42] (ab205199) at 1/1000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal heart lysate at 10 µg
Lane 3:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 79 kDa
Observed band size: 79 kDa
false
Exposure time: 1min
- WB
Supplier Data
Western blot - Anti-FACL4 antibody [EPR17587-42] (AB205199)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-FACL4 antibody [EPR17587-42] (ab205199) at 1/5000 dilution
All lanes:
293 (Human epithelial cells from embryonic kidney) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 79 kDa
Observed band size: 79 kDa
false
Exposure time: 3min
- WB
CiteAb
Western blot - Anti-FACL4 antibody [EPR17587-42] (AB205199)
FACL4 western blot using anti-FACL4 antibody [EPR17587-42] ab205199. Publication image and figure legend from Jiang, Y., Zhao, X., et al., 2020, Nat Commun, PubMed 32312987.
ab205199 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab205199 please see the product overview.
In vitro NIR-II photothermal ferrotherapy.a Confocal laser scanning microscopy (CLSM) images of different types of cancer cells and normal cells after incubation with HSN ([pTBCB] = 50 µg mL−1) or PBS for 24 h. ROS was indicated by green fluorescence from DCF-DA staining. Nuclei were stained with 4′,6-diamidine-2′-phenylindole dihydrochloride (DAPI) and indicated by blue fluorescence. 4T1 : murine mammary carcinoma cell line; MCF-7 : human breast adenocarcinoma cell line; HepG2 : human hepatocellular carcinoma cell line; NIH/3T3 : murine fibroblast cell line; NDF : normal human dermal fibroblast cell line. b Western immunoblot analysis of expression levels of ferroptosis-related proteins (ACSL4, FPN-1, GPX4) in a panel of cancer cell lines. MDA-MB-231 (231) : human breast adenocarcinoma cell line; PC12 : rat pheochromocytoma cell line; HeLa : human cervical adenocarcinoma cell line; SKOV3 : human ovarian adenocarcinoma cell line. Source data were provided in Source Data File. c CLSM images of 4T1 cells after incubation with PBS, HSN, HSN with apoptosis inhibitor DEVD (100 µM), HSN with ferroptosis inhibitor deferoxamine (DFO) (100 µM) for 24 h, respectively. [pTBCB] = 50 µg mL−1. Expression of Cas-3 was indicated by immunofluorescence staining (green fluorescence), and lipid peroxidation was stained with a red-fluorescent probe BODIPY 665/676. Cell viabilities (d) and relative GSH levels (e) of 4T1 cells after incubation with HSN0 or HSN at various concentrations for 24 h with or without 1064 nm photoirradiation (1 W cm−2, 6 min). [pTBCB] = 50 µg mL−1. f Western immunoblots analysis of expression levels of ferroptosis and apoptosis related proteins in 4T1 cells in d and e. Plus and minus symbol indicated with and without photoirradiation, respectively. Source data were provided in Source Data File. g Proposed molecular mechanisms of HSN-mediated NIR-II photothermal ferrotherapy. GSSG glutathione disulfide, AA arachidonic acid, AA-CoA arachidonyl-CoA, LH phospholipid. Error bars indicated standard deviations of three independent measurements.
false
Related conjugates and formulations (1)
-
Anti-FACL4 antibody [EPR17587-42] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FACL4 contributes significantly to lipid metabolism and is involved in the synthesis of complex lipids. It facilitates the integration of long-chain fatty acids into phospholipids and triglycerides. FACL4 often functions as part of larger lipid synthesis and modification complexes working closely with other enzymes to maintain membrane integrity and signal transduction. Its activity influences cellular responses to changes in lipid availability and metabolic demands.
Pathways
FACL4 functions within the arachidonic acid metabolism and glycerophospholipid metabolic pathways. In these pathways other proteins such as COX and LOX interact with FACL4 to regulate inflammatory responses and membrane lipid composition. The enzyme’s role in these pathways highlights its contribution to managing the balance between pro-inflammatory and anti-inflammatory metabolites which are essential for cell signaling and homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (18)
Recent publications for all applications. Explore the full list and refine your search
Dose-response : a publication of International Hormesis Society 23:15593258251335814 PubMed40416644
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 58:e14445 PubMed40367014
2025
Applications
Unspecified application
Species
Unspecified reactive species
CytoJournal 22:28 PubMed40260070
2025
Applications
Unspecified application
Species
Unspecified reactive species
Hereditas 162:47 PubMed40158112
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 24:29 PubMed39856701
2025
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e37087 PubMed39286078
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 300:107680 PubMed39159808
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of nanomedicine 19:7567-7583 PubMed39081897
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell & bioscience 14:71 PubMed38840194
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:79 PubMed38246916
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com